LYEL Lyell Immunopharma, Inc.

Fundamentals / CIK 0001806952 / USD

Lyell Immunopharma, Inc. reported $15K in revenue and a net loss of $255.2M for the trailing twelve months ended September 30, 2026 (down 80.0% year over year), with a -1783580.0% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open LYEL in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$119.7M$59.84M$0-$327.9MFY 2019 Revenue: $657KFY 2019 Net Income: -$129.4M2019FY 2020 Revenue: $7.76MFY 2020 Net Income: -$204.5M2020FY 2021 Revenue: $10.65MFY 2021 Net Income: -$250.2M2021FY 2022 Revenue: $84.68MFY 2022 Net Income: -$183.1M2022FY 2023 Revenue: $130KFY 2023 Net Income: -$234.6M2023FY 2024 Revenue: $61KFY 2024 Net Income: -$343.0M2024FY 2025 Revenue: $36KFY 2025 Net Income: -$274.4M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $36K $61K $130K $84.68M $10.65M $7.76M $657K
Research & Development $158.7M $171.6M $182.9M $159.2M $138.7M $182.2M $63.59M
Total Operating Expenses $269.4M $358.8M $247.1M $271.7M $225.4M $219.7M $102.7M
Operating Income -$269.4M -$358.8M -$247.0M -$187.1M -$214.8M -$211.9M -$102.1M
EBITDA -$257.9M -$339.1M -$226.8M -$169.0M -$201.2M -$207.6M -$100.8M
Income Tax Expense $0 -- -- -- -- -- --
Net Income -$274.4M -$343.0M -$234.6M -$183.1M -$250.2M -$204.5M -$129.4M
Basic EPS -$16.06 -$26.23 -$18.70 -$14.80 -$36.80 -$313.80 -$480.80
Diluted EPS -$16.06 -$26.23 -$18.70 -$14.80 -$36.80 -$313.80 -$480.80
Basic Shares Outstanding 17.1M 13.1M 12.5M 12.4M 6.8M 662.9K 271
Diluted Shares Outstanding 17.1M 13.1M 12.5M 12.4M 6.8M 662.9K 271

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $3.0K $4.0K $2.0K $6.0K $15K $8.0K $7.0K $11K
Research & Development $40.90M $39.52M $36.60M -- $28.17M $34.86M $43.45M --
Total Operating Expenses $48.30M $47.34M $44.26M $127.7M $37.27M $47.15M $57.37M $201.2M
Operating Income -$48.30M -$47.34M -$44.26M -$127.6M -$37.25M -$47.14M -$57.37M -$201.1M
EBITDA -$46.24M -$45.12M -$41.93M -$125.2M -$34.69M -$44.01M -$53.93M -$196.1M
Net Income -$45.53M -$44.76M -$24.15M -$140.7M -$38.85M -$42.68M -$52.20M -$191.9M
Basic EPS -$1.86 -$1.92 -$1.10 -- -$2.13 -$2.89 -$3.54 --
Diluted EPS -$1.86 -$1.92 -$1.10 -- -$2.13 -$2.89 -$3.54 --
Basic Shares Outstanding 24.4M 23.4M 21.9M -- 18.3M 14.8M 14.8M --
Diluted Shares Outstanding 24.4M 23.4M 21.9M -- 18.3M 14.8M 14.8M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $60.18M $105.6M $145.6M $123.6M $293.8M $140.4M
Short-Term Investments $187.0M $264.9M $400.6M $516.6M $321.0M $472.2M
Cash & Short-Term Investments $247.2M $370.5M $546.2M $640.2M $614.8M $612.6M
Total Current Assets $260.9M $379.6M $554.7M $651.3M $626.3M $617.5M
Property, Plant & Equipment, Net $34.77M $48.20M $102.7M $123.0M $120.1M $77.05M
Long-Term Investments $0 $13.01M $16.51M $70.12M $283.5M $80.00M
Other Non-Current Assets $4.89M $4.62M $4.24M $4.68M $3.48M $2.77M
Total Non-Current Assets $79.11M $111.3M $195.3M $286.3M $501.1M $290.7M
Total Assets $340.1M $490.9M $750.0M $937.6M $1.13B $908.3M
Accounts Payable $2.89M $5.37M $4.82M $3.92M $3.21M $9.40M
Deferred Revenue (Current) -- -- -- $0 $4.99M $6.09M
Total Current Liabilities $49.41M $53.79M $34.52M $37.03M $46.74M $49.28M
Deferred Revenue (Non-Current) -- -- -- $0 $79.67M $89.07M
Other Non-Current Liabilities $517K $3.25M $3.66M $4.11M $4.57M $532K
Total Non-Current Liabilities $42.44M $54.25M $60.56M $67.28M $150.9M $140.6M
Total Liabilities $91.85M $108.0M $95.08M $104.3M $197.6M $189.8M
Total Debt (incl. Leases) $50.99M $58.97M $63.17M $67.70M $67.82M $54.57M
Common Stock $2.0K $1.0K $25K $25K $24K $2.0K
Retained Earnings -$1.62B -$1.35B -$1.00B -$767.5M -$584.4M -$334.1M
Accumulated Other Comp. Income $242K $291K -$94K -$7.60M -$1.62M $256K
Total Stockholders' Equity $248.2M $382.8M $655.0M $833.3M $929.8M -$292.5M
Total Equity $248.2M $382.8M $655.0M $833.3M $929.8M -$292.5M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $92.05M $72.98M $90.77M $60.18M $123.6M $98.80M $120.3M $105.6M
Short-Term Investments $85.05M $131.1M $163.3M $187.0M $196.0M $178.0M $180.8M $264.9M
Cash & Short-Term Investments $177.1M $204.1M $254.0M $247.2M $319.6M $276.8M $301.2M $370.5M
Total Current Assets $186.2M $213.5M $267.3M $260.9M $328.2M $282.2M $309.2M $379.6M
Property, Plant & Equipment, Net $28.53M $30.51M $32.72M $34.77M $36.72M $39.12M $44.20M $48.20M
Long-Term Investments $16.88M $23.90M $6.95M $0 $0 $20.06M $28.95M $13.01M
Other Non-Current Assets $5.91M $5.84M $5.23M $4.89M $2.54M $2.53M $3.22M $4.62M
Total Non-Current Assets $87.64M $97.61M $83.32M $79.11M $79.76M $103.2M $120.6M $111.3M
Total Assets $273.9M $311.2M $350.6M $340.1M $408.0M $385.5M $429.8M $490.9M
Accounts Payable $4.04M $3.88M $5.47M $2.89M $2.57M $3.38M $3.73M $5.37M
Total Current Liabilities $46.27M $39.87M $36.95M $49.41M $31.88M $36.90M $41.28M $53.79M
Other Non-Current Liabilities $547K $537K $527K $517K $2.68M $3.03M $3.14M $3.25M
Total Non-Current Liabilities $34.86M $37.47M $40.01M $42.44M $46.97M $49.63M $51.99M $54.25M
Total Liabilities $81.13M $77.34M $76.96M $91.85M $78.84M $86.53M $93.28M $108.0M
Total Debt (incl. Leases) $44.28M $46.60M $48.85M $50.99M $53.07M $55.11M $57.09M $58.97M
Common Stock $2.0K $2.0K $2.0K $2.0K $2.0K $1.0K $30K $1.0K
Retained Earnings -$1.73B -$1.69B -$1.64B -$1.62B -$1.48B -$1.44B -$1.40B -$1.35B
Accumulated Other Comp. Income -$278K -$158K -$9.0K $242K $201K $57K $158K $291K
Total Stockholders' Equity $192.7M $233.8M $273.7M $248.2M $329.1M $298.9M $336.5M $382.8M
Total Equity $192.7M $233.8M $273.7M $248.2M $329.1M $298.9M $336.5M $382.8M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$274.4M -$343.0M -$234.6M -$183.1M -$250.2M -$204.5M -$129.4M
Depreciation & Amortization $11.54M $19.63M $20.25M $18.02M $13.62M $4.29M $1.26M
Stock-Based Compensation $41.83M $33.14M $47.08M $81.92M $62.20M $33.26M $15.73M
Change in Payables -$2.34M -$3.23M $1.46M $667K $91K -$278K $1.71M
Operating Cash Flow -$150.0M -$162.4M -$163.7M -$169.6M -$126.2M -$160.9M $39.47M
Capital Expenditure -$780K -$464K -$2.69M -$24.28M -$65.50M -$51.48M -$16.05M
Free Cash Flow -$150.8M -$162.9M -$166.4M -$193.8M -$191.8M -$212.4M $23.43M
Purchases of Investments -$278.9M -$394.7M -$476.9M -$406.3M -$673.5M -$864.9M -$610.8M
Investing Cash Flow $54.10M $122.4M $184.0M -$11.54M -$121.6M -$273.5M -$422.4M
Common Stock Issued $50.00M $0 $0 -- -- -- --
Share Repurchases -- -- -- $0 $0 -$11.81M -$185K
Financing Cash Flow $50.41M $1.33M $1.74M $10.63M $401.2M $476.8M $351.2M
Net Change in Cash -$45.52M -$38.64M $22.10M -$170.5M $153.4M $42.40M -$31.80M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$45.53M -$44.76M -$24.15M -$140.7M -$38.85M -$42.68M -$52.20M -$191.9M
Depreciation & Amortization $2.05M $2.22M $2.33M $2.40M $2.57M $3.13M $3.44M $5.03M
Stock-Based Compensation $4.51M $4.53M $4.29M $25.57M $5.23M $5.00M $6.02M $8.08M
Change in Payables $144K -$1.46M $2.38M $325K -$779K -$231K -$1.65M -$2.04M
Operating Cash Flow -$34.57M -$33.92M -$38.51M -$32.25M -$28.58M -$34.46M -$54.74M -$47.24M
Capital Expenditure -$66K -$256K -$89K -$304K -$62K -$168K -$246K -$44K
Free Cash Flow -$34.63M -$34.18M -$38.60M -$32.55M -$28.64M -$34.63M -$54.98M -$47.29M
Purchases of Investments -$43.58M -$53.52M -$37.18M -$42.80M -$70.99M -$80.70M -$84.41M -$38.80M
Investing Cash Flow $53.59M $15.62M $17.38M -$31.36M $3.35M $12.65M $69.47M $53.51M
Financing Cash Flow $41K $522K $51.72M $222K $50.00M $183K $1.0K $437K
Net Change in Cash $19.07M -$17.78M $30.59M -$63.39M $24.77M -$21.63M $14.73M $6.70M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -748344.4% -588123.0% -190006.2% -220.9% -2016.7% -2732.6% -15538.7%
Net Profit Margin -762355.6% -562285.2% -180486.2% -216.2% -2349.5% -2636.3% -19692.1%
Return on Equity (ROE) -110.6% -89.6% -35.8% -22.0% -26.9% -- --
Return on Assets (ROA) -80.7% -69.9% -31.3% -19.5% -22.2% -22.5% --
Current Ratio 5.28x 7.06x 16.07x 17.59x 13.40x 12.53x --
Quick Ratio 5.00x 6.89x 15.82x 17.29x 13.15x 12.43x --
Debt to Equity 0.21x 0.15x 0.10x 0.08x 0.07x -- --
Revenue Growth (YoY) -41.0% -53.1% -99.8% +695.1% +37.3% +1080.5% --
Operating Cash Flow Growth (YoY) -- -- -- -- -- -507.5% --
Free Cash Flow Growth (YoY) -- -- -- -- -- -1006.5% --
5Y Revenue / Share Growth -100.0% -100.0% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -1783580.0% -949981.5% -826767.7% -748344.4% -836358.5% -593598.3% -554687.7% -588123.0%
Net Profit Margin -1701066.7% -920285.2% -794858.1% -762355.6% -794292.7% -552328.3% -514649.2% -562285.2%
Return on Equity (ROE) -132.4% -106.3% -90.0% -110.6% -98.9% -110.9% -99.4% -89.6%
Return on Assets (ROA) -93.2% -79.9% -70.3% -80.7% -79.8% -86.0% -77.8% -69.9%
Current Ratio 4.02x 5.36x 7.23x 5.28x 10.30x 7.65x 7.49x 7.06x
Quick Ratio 3.83x 5.12x 6.88x 5.00x 10.03x 7.50x 7.30x 6.89x
Debt to Equity 0.23x 0.20x 0.18x 0.21x 0.16x 0.18x 0.17x 0.15x
Revenue Growth (YoY) -80.0% -50.0% -71.4% -45.5% -55.9% -38.5% +133.3% -15.4%
Source: SEC EDGAR CompanyFacts (CIK 0001806952) · from December 31, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:37 UTC · Open in terminal